Mantica, G.; Chierigo, F.; Malinaric, R.; Smelzo, S.; Ambrosini, F.; Beverini, M.; Guano, G.; Caviglia, A.; Rigatti, L.; De Rose, A.F.;
et al. Intravesical Therapy for Non-Muscle-Invasive Bladder Cancer: What Is the Real Impact of Squamous Cell Carcinoma Variant on Oncological Outcomes? Medicina 2022, 58, 90.
https://doi.org/10.3390/medicina58010090
AMA Style
Mantica G, Chierigo F, Malinaric R, Smelzo S, Ambrosini F, Beverini M, Guano G, Caviglia A, Rigatti L, De Rose AF,
et al. Intravesical Therapy for Non-Muscle-Invasive Bladder Cancer: What Is the Real Impact of Squamous Cell Carcinoma Variant on Oncological Outcomes? Medicina. 2022; 58(1):90.
https://doi.org/10.3390/medicina58010090
Chicago/Turabian Style
Mantica, Guglielmo, Francesco Chierigo, Rafaela Malinaric, Salvatore Smelzo, Francesca Ambrosini, Martina Beverini, Giovanni Guano, Alberto Caviglia, Lorenzo Rigatti, Aldo Franco De Rose,
and et al. 2022. "Intravesical Therapy for Non-Muscle-Invasive Bladder Cancer: What Is the Real Impact of Squamous Cell Carcinoma Variant on Oncological Outcomes?" Medicina 58, no. 1: 90.
https://doi.org/10.3390/medicina58010090
APA Style
Mantica, G., Chierigo, F., Malinaric, R., Smelzo, S., Ambrosini, F., Beverini, M., Guano, G., Caviglia, A., Rigatti, L., De Rose, A. F., Tafuri, A., De Marchi, D., Gaboardi, F., Suardi, N., & Terrone, C.
(2022). Intravesical Therapy for Non-Muscle-Invasive Bladder Cancer: What Is the Real Impact of Squamous Cell Carcinoma Variant on Oncological Outcomes? Medicina, 58(1), 90.
https://doi.org/10.3390/medicina58010090
